PubHealth.info® (An Information Portal on Public Health Issues / Topics, Presented in Collaboration with PakMed Biomedical Solutions)

[PubHealth.info Homepage] [Category Homepage] [Disclaimer/Copyrights] [Feedback]


Thank you for your kind visit to PubHealth.info®, an information portal created in technical collaboration with PakMed Biomedical Solutions * * * PubHealth.info® presents hundreds of thousands of informative Web pages on a variety of public health issues / issues * * * An ultimate source of information for teachers, students and research workers who need to find information on various public health issues, like population planning, contraception, HIV AIDS, STDs, maternal and child health, communicable and non-communicable disease, etc. * * * PubHealth.info® regularly updates the repository of these hundreds of thousands of informative Web pages * * * PubHealth.info® is one of the world's largest repositories and information portals with online Web pages on public health issues particularly those pertaining to developing countries!

PubHealth.info® (a subsidiary of PakMed) presents scientific information mainly based on abstracts of articles published on a variety of public health issues/topics, particularly encompassing population planning, disease prevention, maternal and child health, and communicable and non-communicable diseases (like HIV AIDS, malaria, etc) that are affecting a significant portion of population in developing and developed countries. Here you can find abstracts of articles published on a variety of public health topics under category "Contraception (Birth Control) and Family Planning". Contraception (birth control) is a regimen of one or more actions, devices, or medications followed in order to deliberately prevent or reduce the likelihood of a woman becoming pregnant or giving birth. Therefore contraception is the utilization of various and sundry surgical procedures, devices, practices, agents, or drugs with the intention of preventing conception or impregnation (pregnancy). Methods and intentions typically termed birth control may be considered a pivotal ingredient to family planning. Birth control is a controversial political and ethical issue in many cultures and religions, and although it is generally less controversial than abortion specifically.

Here you can find more than 42,000 article titles on "Contraception (Birth Control) and Family Planning" , along with their abstracts and bibliographic information (one of the world's largest collections of article titles on this topic), mentioned in various lists that are sorted/arranged according to the years of publication. You can view the bibliographic details and abstracts of these articles, by clicking the title of your required article. To view other lists of articles in the same category "Contraception (Birth Control) and Family Planning", please visit "Category Lists Homepage" or select a list from the following dropdown list of article titles.

 

List 07: Articles 3001-3500 (500 Articles)

To view other lists in the same category, please VISIT LISTS HOME PAGE or select a list from the above dropdown list of article titles
  1. Sex differences in barriers to contraceptive use among adolescents.
  2. Sexual activity and contraceptive practices among teenagers in the United States, 1988 and 1995.
  3. Sexual and contraceptive experience of young adults.
  4. Sexual behavior and contraception among adolescents.
  5. Sexual behaviour and contraceptive use among secondary school adolescents in Benin City, Nigeria.
  6. Sexuality and contraception.
  7. Sexuality, partner relations and contraceptive practice after termination of pregnancy.
  8. Should access to birth control be streamlined?
  9. Social networks and contraceptive dynamics in southern Ghana.
  10. Son preference and family planning practices among married men in Mumbai, India.
  11. Sperm finding could lead to fertility help, contraceptive.
  12. Spermicidal intravaginal contraception. [La contraception locale spermicide.]
  13. Spermistatics may lead to new contraceptives.
  14. Spotlight -- India. Friends of the Pill. Expanding the market for oral contraceptives in north India.
  15. Study of interspouse communication and adoption of family planning and immunization services in a rural block of Varanasi district.
  16. A study of the relationship between oral contraceptives and gene polymorphism and types of stroke.
  17. Study on weekly low doses of mifepristone for contraception.
  18. Successful use of oral contraceptives.
  19. A suitable job for a woman: women doctors and birth control to the inception of the NHS.
  20. A survey of attitudes to abortion law in Northern Ireland amongst obstetricians, gynaecologists and family planning doctors.
  21. Taking up the challenge: Can effective long-term intra-uterine contraceptive methods radically reduce the number of unintended pregnancies? [editorial]
  22. The Tanzania Family Planning Training Program. The impact of an innovative training strategy on reproductive and child health service performance of health attendants in Tanzania.
  23. Tetracycline treatment, oral contraceptives and pregnancy. [Tetracyclinbehandling, p-piller og graviditet.]
  24. Thromboembolic complications of oral estrogen-gestagen contraception. [Tromboembolické komplikace uzívání orálnIí estrogen-gestagenní antikoncepce.]
  25. Toward optimal health: the experts discuss oral contraception.
  26. Transcultural aspects of family planning and reproductive healthcare [editorial] [Aspects transculturels du planning familial et des soins de santé reproductive] [éditorial.]
  27. Transdermal contraception.
  28. Transdermal contraceptive patch awaiting US approval.
  29. Transdermal contraceptive system.
  30. Transdermal hormonal contraceptive patch safe and effective.
  31. Trends and determinants of contraceptive utilization in Indonesia. [Tendances et déterminants de l'usage du contraceptif en Indonésie.]
  32. Trials of male contraceptive.
  33. Two-thirds of sexually active Thai teens don't use condoms, other contraception.
  34. U.S. women are waiting for contraceptive sponge. [Les femmes américaines attendent l'éponge contraceptive.]
  35. Understanding low-dose oral contraceptives. Complications.
  36. Understanding low-dose oral contraceptives. Current OC formulations.
  37. Understanding low-dose oral contraceptives. Efficacy.
  38. Understanding low-dose oral contraceptives. Generic equivalent OCs.
  39. Understanding low-dose oral contraceptives. Improving real-use efficacy.
  40. Understanding low-dose oral contraceptives. Noncontraceptive health benefits.
  41. Understanding low-dose oral contraceptives. Side effects and discontinuation.
  42. Understanding low-dose oral contraceptives. Summary and recommendations.
  43. Understanding men's role in family planning in Pakistan.
  44. Unmet need for contraception in South Asia: levels, trends and determinants.
  45. Unmet need for family planning.
  46. Update: the media and contraception.
  47. Uptake of family planning in Pakistan: trends and emerging issues.
  48. US employers' health insurance must cover contraceptives.
  49. USAID's family planning services.
  50. USAID: ensuring quality family planning services throughout the world.
  51. Use of a low-dose oral contraceptive containing norethindrone acetate and ethinyl estradiol in the treatment of moderate acne vulgaris.
  52. Use of condoms and other contraceptive methods by HIV-infected and at-risk women.
  53. The use of emergency contraception in Australasian emergency departments.
  54. Use of emergency contraception in the UK.
  55. Use of hormonal emergency contraception at a university health centre over a 6 year period. [Utilisation de la contraception hormonale d'urgence dans un centre hospitalier universitaire sur une période de 6 ans.]
  56. Use of the novel combined contraceptive vaginal ring NuvaRing for ovulation inhibition.
  57. Use of the same language facilitates the diffusion of contraceptive methods. [L'emploi d'une meme langue facilite la diffusion des moyens contraceptifs.]
  58. Users perspective on the quality of family planning services and care: evidence from four Indian states.
  59. Using cognitive theory to improve nurse practitioners' anticipatory guidance with contraceptive pill users.
  60. Using oral contraceptives to treat polycystic ovary syndrome.
  61. Utilization of birth control services among homeless women.
  62. Vaginal ring hormone delivery systems in contraception and menopause.
  63. Vatican opposes emergency contraception for refugees.
  64. A village would be nice but ... it takes a long-acting contraceptive to prevent repeat adolescent pregnancies.
  65. Voluntary participation and informed choice in family planning.
  66. What do pupils and students know about contraceptive methods? [Quel est l'état des connaissances des élèves et des étudiants en matière de méthodes contraceptives ?]
  67. What to expect in the next five years? Innovative contraceptive delivery. Patches, rings, implants and gels are in research.
  68. What to say when speaking of emergency contraception. [De que falamos quando falamos de contracepcao de emergencia.]
  69. Which contraception to choose for the diabetic woman? [Quelle contraception choisir pour la femme diabetique?]
  70. Which contraception to choose for the diabetic woman? [Quelle contraception choisir pour la femme diabetique?]
  71. WHO 2000 contraceptive medical eligibility guidelines.
  72. Wider availability of emergency contraception.
  73. Will the pill make me sterile? Addressing reproductive health concerns and strategies to improve adherence to hormonal contraceptive regimens in adolescent girls.
  74. Women's use of contraception in rural India: a village-level study.
  75. World leaders agree at close of unprecedented global meeting. Crisis of shortages of contraceptives and condoms for HIV / AIDS prevention is real.
  76. Contraceptive need among Cambodian refugees in Khao Phlu Camp.
  77. Effects of an entertainment-education radio soap opera on family planning and HIV prevention in St. Lucia.
  78. Empirical assessments of social networks, fertility and family planning programs: nonlinearities and their implications.
  79. Why are U.S. women not using long-acting contraceptives?
  80. Factors affecting contraceptive use in women seeking pregnancy tests: Missouri, 1997.
  81. The relationship context of contraceptive use at first intercourse.
  82. Are there unmet family planning needs in Europe?
  83. Contraceptive use in Canada: 1984-1995.
  84. Islamic precepts and family planning: the perceptions of Jordanian religious leaders and their constituents.
  85. Fertility preferences and contraceptive change in developing countries.
  86. Measuring family planning service quality through client satisfaction exit interviews.
  87. Do service providers in Tanzania unnecessarily restrict clients' access to contraceptive methods?
  88. Adolescent perceptions of maternal approval of birth control and sexual risk behavior.
  89. Comparative effects of Lunelle monthly contraceptive injection (medroxyprogesterone acetate and estradiol cypionate injectable suspension) and Ortho-Novum 7/7/7 oral contraceptive (norethindrone / ethinyl estradiol triphasic) on lipid profiles.
  90. Comparison of ovarian follicular activity during treatment with a monthly injectable contraceptive and a low-dose oral contraceptive.
  91. A 10-year follow-up study of contraceptive Norplant implants.
  92. Acculturation and attitudes about contraceptive use among Latina women.
  93. Adolescent girls with illegally induced abortion in Dar es Salaam: the discrepancy between sexual behaviour and lack of access to contraception.
  94. Adolescent perceptions of maternal approval of birth control and sexual risk behavior.
  95. Audit of outcome following positive chlamydial test results in family planning clinics in Southampton.
  96. Bacterial vaginosis and contraceptive methods.
  97. Birth control method choice and use of barrier methods for sexually transmitted disease prevention among low-income African-American women.
  98. Bleeding patterns of women using Lunelle monthly contraceptive injections (medroxyprogesterone acetate and estradiol cypionate injectable suspension) compared with those of women using Ortho-Novum 7/7/7 (norethindrone / ethinyl estradiol triphasic) or other oral contraceptives.
  99. Bone mineral density during long-term use of the progestagen contraceptive implant Implanon compared to a non-hormonal method of contraception.
  100. Cardiovascular issues with oral contraceptives: evidenced-based medicine.
  101. Clinical performance of the levonorgestrel intra-uterine system in routine use by the UK Family Planning and Reproductive Health Research Network: 12-month report.
  102. Clinical performance of the Nova-T 380 IUD in routine use by the UK Family Planning and Reproductive Health Research Network: 12-month report.
  103. Collagen metabolism markers as a reflection of bone and soft tissue turnover during the menstrual cycle and oral contraceptive use.
  104. Contraceptive and reproductive risk factors for cervical intraepithelial neoplasia in American Indian women.
  105. Contraceptive requirements for clinical research.
  106. Contraceptive use at first intercourse among Jewish women in Israel, 1962-1988.
  107. The demand and supply of nutritional advice and guidance in Scottish family planning services.
  108. A detailed analysis of menstrual blood loss in women using Norplant and Nestorone progestogen-only contraceptive implants or vaginal rings.
  109. Detecting cervical infection among family planning clients: difficulties at the primary health-care level in Indonesia.
  110. Determinants of contraceptive use and method choice in Turkey.
  111. Determinants of current use of contraception and children ever born in Nepal.
  112. Differences between users and non-users of emergency contraception after a recognized unprotected intercourse.
  113. Disability, space and sexuality: access to family planning services.
  114. Ectopic gestation following emergency contraceptive pill administration.
  115. The effect of gender preference on contraceptive use and fertility in rural Egypt.
  116. The effect upon the human vaginal histology of the long-term use of the injectable contraceptive Depo-Provera.
  117. The effects of family planning education provided to different gender groups.
  118. Effects of oral contraceptive pill use on vaginal flora and vaginal epithelium.
  119. Effects of oral contraceptives on vascular endothelium in premenopausal women.
  120. Effects of the etonogestrel-releasing contraceptive implant (Implanon) on parameters of breastfeeding compared to those of an intrauterine device.
  121. Effects of two oral contraceptives on plasma levels of insulin-like growth factor I (IGF-I) and growth hormone (hGH)
  122. Efficacy and acceptability of testosterone implants, alone or in combination with a 5 alpha-reductase inhibitor, for male hormonal contraception.
  123. Efficacy, acceptability, and clinical effects of a low-dose injectable contraceptive combination of dihydroxyprogesterone acetophenide and estradiol enanthate.
  124. Efficacy, cycle control, and safety of two triphasic oral contraceptives: Cyclessa (desogestrel / ethinyl estradiol) and Ortho-Novum 7/7/7 (norethindrone / ethinyl estradiol). A randomized clinical trial.
  125. Emergency contraception in clinical practice: global perspectives.
  126. Emergency contraception: a review of the programmatic and social science literature.
  127. Emergency contraception: advance provision in a young, high-risk clinic population.
  128. Emerging evidence on oral contraceptives and arterial disease.
  129. Evaluating contraceptive choice through the method-mix approach: an Indian Council of Medical Research (ICMR) task force study.
  130. Evidence that treatment with monophasic oral contraceptive formulations containing ethinylestradiol plus gestodene reduces bone resorption in young women.
  131. Expanding contraceptive choices: Lunelle monthly contraceptive injection.
  132. Family planning and sexual behavior in the era of HIV / AIDS: the case of Nakuru district, Kenya.
  133. Family planning clinic patients: their usual health care providers, insurance status, and implications for managed care.
  134. Family planning services at school-based health centers: findings from a national survey.
  135. Forty years of combined oral contraception: the evolution of a revolution.
  136. Gossypol blood levels and inhibition of spermatogenesis in men taking gossypol as a contraceptive. A multicenter, international, dose-finding study.
  137. Hemostatic effects of third- and second-generation oral contraceptives: absence of a causal mechanism for a difference in risk of venous thromboembolism.
  138. How well do perceptions of family planning service quality correspond to objective measures? Evidence from Tanzania.
  139. Husbands' versus wives' fertility goals and use of contraception: the influence of gender context in five Asian countries.
  140. The impact of mass media family planning programmes on current use of contraception in urban Bangladesh.
  141. The influence of husbands on contraceptive use by Bangladeshi women.
  142. Informed consent for emergency contraception: variability in hospital care of rape victims.
  143. Integration of prevention and care of sexually transmitted infections with family planning services: what is the evidence for public health benefits?
  144. International actors and population policies in India, with special reference to contraceptive policies.
  145. Is low income a constraint to contraceptive use among the Pakistani poor?
  146. Ischemic stroke risk with oral contraceptives. A meta-analysis.
  147. Knowledge and attitudes about emergency contraception in a military population.
  148. Knowledge and use of emergency postcoital contraception by female students at a high school in Nova Scotia.
  149. Knowledge and willingness to use emergency contraception among low-income post-partum women.
  150. Latin American experience with two low-dose oral contraceptives containing 30 micrograms ethinylestradiol / 75 micrograms gestodene and 20 micrograms ethinylestradiol / 150 micrograms desogestrel.
  151. Levonorgestrel-releasing (20 micrograms / day) intrauterine systems (Mirena) compared with other methods of reversible contraceptives.
  152. Low-dose contraceptive estrogen-progestin and coronary artery atherosclerosis of monkeys.
  153. Low-dose oral contraceptives and bone mineral density: an evidence-based analysis.
  154. Low-dose oral contraceptives: health consequences of discontinuation.
  155. Mass media exposure and its impact on family planning in Bangladesh.
  156. Matrix metalloproteinase-1 and -3 and mast cells are present in the endometrium of women using progestin-only contraceptives.
  157. Menstrual patterns and fecundity among non-lactating and lactating cycling women in rural highland Bolivia: implications for contraceptive choice.
  158. Mesigyna once-a-month combined injectable contraceptive: experience in Latin America.
  159. Minimal smoking cessation interventions in prenatal, family planning, and well-child public health clinics.
  160. Mobilizing demand for contraception in rural Gambia.
  161. A multicentered clinical trial of the long-acting injectable contraceptive Depo Provera in Chinese women.
  162. New contraceptive eligibility checklists for provision of combined oral contraceptives and depot-medroxyprogesterone acetate in community-based programmes.
  163. A new vaginal antimicrobial contraceptive formulation: phase I clinical pilot studies.
  164. Noncontraceptive benefits of oral contraceptive use: an evidence-based approach.
  165. Once a month administration of mifepristone improves bleeding patterns in women using subdermal contraceptive implants releasing levonorgestrel.
  166. An open-label, multicenter study to evaluate Yasmin, a low-dose combination oral contraceptive containing drospirenone, a new progestogen.
  167. Oral contraception and cardiovascular risk factors during adolescence.
  168. Oral contraceptive use and glucose metabolism in a national sample of women in the United States.
  169. Oral contraceptives and benign ovarian tumors.
  170. Oral contraceptives and bone mineral density: a population-based study.
  171. Oral contraceptives and cardiovascular outcomes: cause or bias?
  172. Oral contraceptives and epithelial ovarian cancer. Does dose matter?
  173. Oral contraceptives do not affect magnesium in breast milk.
  174. Patterns of contraceptive use in 5 European countries.
  175. Perceptions of hormonal contraceptive safety and side effects among low-income Latina and non-Latina women.
  176. Postoperative administration of monophasic combined oral contraceptives after laparoscopic treatment of ovarian endometriomas: a prospective, randomized trial.
  177. Potential impact of hormonal male contraception: crosscultural implications for development of novel preparations.
  178. The potential role of contraception in reducing abortion.
  179. Power and negotiation: young women's choices about sex and contraception.
  180. The power of information and contraceptive choice in a family planning setting in Mexico. [El poder de la información y la elección de anticonceptivos en un entorno de planificación familiar en México.]
  181. Premenopause contraception with monthly injectable Mesigyna with special emphasis on serum lipid and bone density patterns.
  182. Prevalence of enlarged ovarian follicles among users of levonorgestrel subdermal contraceptive implants (Norplant)
  183. Provision of emergency contraceptive pills to spermicide users in Ghana.
  184. Recurrent use of newer oral contraceptives and the risk of venous thromboembolism.
  185. Reducing unintended pregnancy by increasing access to emergency contraceptive pills.
  186. Relationship of hormonal contraception and cervical ectopy as measured by computerized planimetry to chlamydial infection in adolescents.
  187. Religiosity and contraceptive method choice: the Jewish population of Israel.
  188. Repeated use of hormonal emergency contraception by younger women in the UK.
  189. Rheological properties of contraceptive gels.
  190. Risk of breast cancer with oral contraceptive use in women with a family history of breast cancer.
  191. Risk of ovarian cancer in relation to estrogen and progestin dose and use characteristics of oral contraceptives.
  192. The role of couple negotiation in unmet need for contraception and the decision to stop childbearing in Uganda.
  193. Sexual behaviour and contraception among unmarried adolescents and young adults in greater Accra and eastern regions of Ghana.
  194. Sexual initiation and contraceptive use among adolescent women in northeast Brazil.
  195. Sexually transmitted diseases in a family planning and an antenatal clinic in Peru. Limitations of current practices and analysis of the use of potential markers, pH testing, and whiff testing.
  196. Spousal communication and contraceptive use among the Yoruba of Nigeria.
  197. Testicular heat exposure enhances the suppression of spermatogenesis by testosterone in rats: the "two-hit" approach to male contraceptive development.
  198. Transforming family planning programmes: towards a framework for advancing the reproductive rights agenda.
  199. Trends and determinants of contraceptive use in Rakai district, Uganda, 1995-98.
  200. Use of birth control pills, condoms, and withdrawal among U.S. high school students.
  201. Vaginal epithelial surface appearances in women using vaginal rings for contraception.
  202. Venous thromboembolism and combined oral contraceptives: does the type of progestogen make a difference?
  203. Women's knowledge of, and attitudes to, contraceptive effectiveness and adverse health effects.
  204. Contraception controversy: can employers refuse to pay for the pill?
  205. Global estimates of contraceptive commodities and condoms for STI / HIV prevention, 2000-2015.
  206. Unmet need for family planning: a comparative analysis of northern and southern states of India based on NFHS data.
  207. Women and contraception: knowledge and use of contraceptive methods. [Mulher e anticoncepçao: conhecimento e uso de métodos anticoncepcionais.]
  208. Developing family planning standards in Jamaica.
  209. Tanzania: responsive training and learning. Innovative training in family planning for health attendants.
  210. USAID / Mexico population, family planning and reproductive health program, 1992-1999. [USAID / población mexicana, programa de planificación familiar y salud reproductiva, 1992-1999.]
  211. USAID. Support for family planning and reproductive health programs in Brazil. [USAID. Apoyo para los programas de planificación familiar y de salud reproductiva en Brasil.]
  212. Guide for incorporating gender considerations in USAID's family planning and reproductive health RFAs and RFPs.
  213. Future trends in contraception in the developing world: prevalence and method mix.
  214. Integrating issues of sexuality into Egyptian family planning counseling.
  215. Spatial variation in contraceptive use in Bangladesh: looking beyond the borders.
  216. Unmet need for family planning in developing countries and implications for population policy.
  217. Egypt: family planning providers should encourage clients to discuss sexual problems.
  218. Kenya: postabortion care. Offer family planning on hospital wards.
  219. The costs of integrating reproductive health services: an example using syndromic management of STIs in family planning clinics in Zimbabwe.
  220. Factors influencing the growth of the commercial sector in family planning service provision.
  221. Women's work, fertility level and contraceptive use: a synthesis of results from Bolivia, the Philippines and Zimbabwe. [Mujeres: trabajo, nivel de fertilidad y uso de anticonceptivos. Síntesis de los resultados de Bolivia, las Filipinas y Zimbabwe.]
  222. Understanding clients' choice of providers and their willingness to pay for family planning services in the Philippines.

     

  223. California guidelines for pharmacies providing family planning services to the community.
  224. A clinician's guide to providing emergency contraceptive pills.
  225. Comprehensive reproductive health and family planning training curriculum. Module 9: Condoms and spermicides.
  226. Comprehensive reproductive health and family planning training curriculum. Module 5: Emergency contraceptive pills.
  227. Comprehensive reproductive health and family planning training curriculum. Module 12: Prevention and management of reproductive tract infections (RTIs). Participant's manual.
  228. Comprehensive reproductive health and family planning training curriculum. Module 12: Prevention and management of reproductive tract infections (RTIs)
  229. Comprehensive reproductive health and family planning training curriculum. Module 11: Manual vacuum aspiration (MVA) for treatment of incomplete abortion. Participant's manual.
  230. Comprehensive reproductive health and family planning training curriculum. Module 11: Manual vacuum aspiration (MVA) for treatment of incomplete abortion.
  231. Emergency contraception. [Anticoncepción de emergencia.]
  232. The need for family planning. [Necesidad de planificación familiar.]
  233. The substitution of contraception for abortion in Kazakhstan in the 1990s.
  234. Client-provider interactions in family planning services: guidance from research and program experience.
  235. Teen sex, contraception and pregnancy. Fact sheet.
  236. Emergency contraception. Facts.
  237. Hormonal contraceptive use in a rural District of Nepal.
  238. The Care for Health Campaign: making family planning a household norm in Russia.
  239. Emergency contraceptive pills.
  240. Study of unmet need for family planning among married women of reproductive age attending immunization clinic in a medical college of Calcutta.
  241. Comparative study of under five deaths and family planning status in district Ahmedabad.
  242. Population control? Women's health = birth control?
  243. Couples' reports of their contraceptive use: do husbands in Africa overstate the case?
  244. Shifting to a sexual and reproductive health approach: challenges for family planning providers.
  245. Effort indices for national family planning programs, 1999 cycle.
  246. The evolution of contraceptive pricing in Indonesia: a final report to the POLICY Project.
  247. Expenditures for reproductive health and family planning services in Egypt and Sri Lanka.
  248. Fertility transition, contraceptive use, and abortion in rural Bangladesh: the case of Matlab.
  249. From home to the clinic: the next chaper in Bangladesh's family planning success story urban sites.
  250. Selected health policy issues : strategy and plan of action regarding contraceptive security calculations and steps to promote FP / RH policy diaglogue among partners in Madagascar. [Choix de questions de politique de santé : stratégie et plan d'action sur les calculs en matière de sécurité contraceptive et mesures de promotion du dialogue PF/SR chez les partenaires à Madagascar.]
  251. Shifting family planning services from home to the clinic: evidence from urban Bangladesh.
  252. From the home to the clinic: the next chapter in Bangladesh's family planning success story. Rural sites. Revised.
  253. Effort scores for family planning programs: an alternative approach.
  254. Abortion and contraceptive use in Turkey.
  255. Contraceptive dynamics among the Mayan population of Guatemala: 1978-1998. [Dinámicas de anticoncepción entre la población Maya de Guatemala: 1978-1998.]
  256. Skewed method mix: a measure of quality in family planning programs.
  257. The stymied contraceptive revolution in Guatemala. [La frustrada revolución anticonceptiva en Guatemala.]
  258. Linking family planning with other social services: the perspectives of state family planning administrators.
  259. Revisiting the link between family planning and other social services.
  260. Community-based distribution of family planning as perceived by people in the reproductive age group, North and South Gondar zones, Ethiopia.
  261. Contraceptive prevalence and factors associated with usage of contraceptives around Gondar Town.
  262. Knowledge, practice, and impact of family planning among pregnant women at Woreda 23 Health Center.
  263. The operational aspect of population and family planning program implementation.
  264. Hormonal contraception for human males: prospects.
  265. Interference with the formation of the epididymalmicroenvironment -- a new strategy for male contraception?
  266. Male contraception: prospects for the new millennium.
  267. Low dose gossypol for male contraception.
  268. Constraints in the development of contraceptives for men.
  269. Despite their elevated risk, very few women who use oral contraceptives will experience an ischemic stroke.
  270. In clinical trial, women using once-a-month injectable contraceptive avoid pregnancy and approve of method.
  271. Forum: the pill at 40 -- a new look at a familiar method. The pill and men's involvement in contraception.
  272. Providers, clients okay emergency contraception in Nairobi and Mexico City.
  273. Women's exposure to mass media is linked to attitudes toward contraception in Pakistan, India and Bangladesh.
  274. Promoting contraceptive use and choice: France's approach to teen pregnancy and abortion.
  275. Knowledge about reproduction, contraception, and sexually transmitted infections among young adolescents in American cities.
  276. The relationship between barriers to birth control use and actual birth control use among Mexican-American adolescents.
  277. The logistics handbook. A practical guide for supply chain managers in family planning and health programs.
  278. The contraceptive forecasting handbook for family planning and HIV / AIDS prevention programs.
  279. Philippines: contraceptive logistics system. Review of accomplishments and lessons learned (1991-1997)
  280. Peru: contraceptive logistics system. Review of accomplishments and lessons learned (1994-1999) [Perú: sistema de logística anticonceptiva. Revisión de los logros y las lecciones aprendidas (1994-1999)]
  281. Nepal: contraceptive and drugs logistics system. Review of accomplishments and lessons learned (1993-2000)
  282. Jordan: contraceptive logistics system. Review of accomplishments and lessons learned (1997-2000)
  283. Oral contraceptives -- an update./Contraceptifs oraux-une mise a jour./Los anticonceptivos orales hoy dia.
  284. Competing interests and controversy about third generation oral contraceptives.
  285. Competing interests and controversy about third generation oral contraceptives. Editor's reply [letter]
  286. Competing interests and controversy about third generation oral contraceptives. Science is not a dispassionate activity [letter]
  287. Consultation patterns and provision of contraception in general practice before teenage pregnancy: case-control study.
  288. Ectopic pregnancy with oral contraceptive use has been overlooked [letter]
  289. Effect of 1995 pill scare on rates of venous thromboembolism among women taking combined oral contraceptives: analysis of General Practice Research Database.
  290. Incidence of venous thromboembolism in users of combined oral contraceptives. Authors' reply [letter]
  291. Incidence of venous thromboembolism in users of combined oral contraceptives. Methods for identifying cases and estimating person time at risk must be detailed [letter]
  292. Incidence of venous thromboembolism in users of combined oral contraceptives. Risk is particularly high with first use of oral contraceptives [letter]
  293. Never underestimate the force of reproduction. Effective contraception for teenagers requires a change in medical culture [editorial]
  294. Population, consumption, and entrapment. Improve access to contraception to curb population growth [letter]
  295. Risk of venous thromboembolism among users of third generation oral contraceptives compared with users of oral contraceptives with levonorgestrel before and after 1995: cohort and case-control analysis.
  296. Third generation oral contraceptives. Caution is still justified.
  297. User-fees for family-planning methods: an analysis of payment behaviour among urban contraceptors in Bangladesh.
  298. Questionnaire. International Family Planning Program Study -- 1999 cycle.
  299. Combined hormonal contraceptive patch.
  300. Combined oral contraceptives do not increase the risk of back and pelvic pain during pregnancy or after delivery.
  301. Communicating safe motherhood in Morocco. The Family Planning / Maternal and Child Health Phase V Project. Final report.
  302. Communication in safe motherhood in Morocco: Family Planning and Maternal and Child Health project. Phase V. Final report, March 2000. [La communication dans la maternité sans risque au Maroc: le project de planification familiale et de sante de la mère et de l'enfant. Phase V. Rapport final, Mars 2000.]
  303. Community Based Family Planning Project, Family Planning Association of Nepal.
  304. Comparative contraception: progestin-releasing IUD's, subdermal implants, contraceptive vaginal rings, emergency contraceptives, OC, COC.
  305. Comparative study on the effects of two contraceptive injections (Mesigyna, Cyclofem) on blood coagulation and fibrinolysis.
  306. Contraception -- consumer perspectives; past, present and future.
  307. Contraception 2000: Lunelle, an injectable combination contraceptive option.
  308. Contraception and abortion in Cuba. [Anticoncepcion y aborto en Cuba.]
  309. Contraception and the menopause.
  310. Contraception for adolescents: evidence-based case review.
  311. Contraception for the older woman -- a century of change.
  312. Contraception for the under 20s.
  313. Contraception in the world: inequalities of access still very great. [Contraception dans le monde: des inegalites d'acces encore tres fortes.]
  314. Contraception.
  315. 1999 contraceptive social marketing statistics.
  316. The abortifacient effect of the birth control pill and the principle of 'double effect'.
  317. Abortion in Africa: a birth control method and a public health issue.
  318. Abortion in Africa: birth control method and public health problem. [L'avortement en Afrique: mode de controle des naissances et probleme de sante publique.]
  319. Access to emergency contraception. [Accès aux contraceptifs d'urgence.]
  320. Adolescent contraception: survey of attitudes and practice of health professionals.
  321. Adolescent medicine. Contraception.
  322. Advances in contraception.
  323. Analysis of contraceptive knowledge among married reproductive women in China.
  324. Analysis on the emergency contraception knowledge level and its influencing factors among abortion patients in Shanghai city.
  325. Analysis says boost in overseas family planning aid would yield improved health, fewer abortions.
  326. Appraising the role of reproductive health, family planning, maternal and child care in the context of population stabilization in Africa.
  327. Approaches to natural family planning [letter]
  328. Approaches to natural family planning. Reply of the authors [letter]
  329. Are computers of any use in a family planning clinic?
  330. Are status of women and contraceptive prevalence correlated in Pakistan?
  331. Assessing the quality of facility-level family planning services in Malawi.
  332. Assessment of the quality of data collection and recording procedures of the maternal and child health and family planning programs. [Appreciation de la qualite de la collecte et des procedures d'enregistrement des donnees des programmes SMI / PF.]
  333. The associations among pediatricians' knowledge, attitudes, and practices regarding emergency contraception.
  334. Australia's contribution to family planning, reproductive health and population programs in the Pacific Islands and Papua New Guinea.
  335. Authenticity of family planning performance statistics in Dharwad district, Karnataka.
  336. Bangladesh: contraceptive logistics system. Review of accomplishments and lessons learned.
  337. Birth control injections (the shot)
  338. Birth control pills.
  339. The blurred line between aiding progress and sanctioning abuse: United States appropriations, the UNFPA and family planning in the P.R.C.
  340. The "boom and bust phenomenon": the hopes, dreams, and broken promises of the contraceptive revolution.
  341. Breast and pelvic examinations in women taking oral contraceptives.
  342. Building sustainability through better management, 1995-2000. Family Planning Management Development project. The FPMD project: a fifteen-year legacy.
  343. California program shows benefits of expanding family planning eligibility.
  344. CE-Marking on contraceptive devices: what does it mean?
  345. Changing lives, saving lives. Lessons from the Family Planning Services Project. End of project conference, September 11, 2000, Washington, D.C.
  346. Checklist for family planning service delivery, with selected linkages to reproductive health. Maximizing access and quality. MAQ.
  347. A checklist for ruling out pregnancy in women seeking contraception in Kenya.
  348. Choices: "the pill" combined oral contraceptive.
  349. Choices: a guide to family planning.
  350. Client-provider interaction curriculum. Module No. 6: Counseling about side effects of contraceptives.
  351. Clinical contraception in a rural NGO area in Bangladesh: findings of a baseline study.
  352. Clinical preliminary study on biodegradable subcutaneous contraceptive implant -- CaproF.
  353. Contraception.
  354. Contraception: the past 25 years.
  355. Contraceptive behaviour of married adolescents in Bangladesh: evidence from Bangladesh Demographic and Health Survey, 1993-94.
  356. Contraceptive decision making among medicaid-eligible women.
  357. Contraceptive devices and the Medical Devices Directive.
  358. Contraceptive eligibility checklists for community-based services.
  359. Contraceptive equity bills continue to gain. [Accroissement des valeurs boursières des contraceptifs.]
  360. Contraceptive intentions of women seeking induced abortion in the city of Jos, Nigeria.
  361. Contraceptive knowledge and expectations by adolescents: an explanation by focus groups.
  362. Contraceptive methods and breast cancer risk: an update.
  363. The contraceptive revolution [editorial]
  364. The contraceptive revolution in Israel: changing family planning practices among ethnoimmigrant groups.
  365. Contraceptive use and method choice at initial sex among married reproductive women.
  366. Contraceptives and teens: what are the options?
  367. Contraceptives for the 21st century.
  368. Cost-effectiveness of USAID's regional support of family planning in West Africa: interim report.
  369. Coverage of gynecological care and contraceptives.
  370. Cultural perspectives on contraception: a literature review.
  371. The current status of intra-uterine contraceptive devices and systems.
  372. Current status of statistical data sources on population and family planning. [Etat actuel des sources de donnees statistiques en population et planification familiale.]
  373. The Daily PLANet Media Response Initiative (MRI). Report on a series of meetings. Building a rapid response team on international family planning issues in the news media.
  374. A decade of unmet need for contraception in Ghana: programmatic and policy implications.
  375. Delivery of primary care services among family planning centers: a response to managed care?
  376. Demographic policies, family planning and fertility transition in Africa.
  377. Demographic policy, family planning and the fertility transition in Africa. [Politique demographique, planification familiale et transition de la fecondite en Afrique.]
  378. Determinants of current contraceptive use among Nepalese women: an analysis of NFH survey 1991.
  379. The determinants of the use of alternative methods of contraception among South African women.
  380. Development of a scale to assess maternal and child health and family planning knowledge level among rural women.
  381. Development of contraceptive implants.
  382. The development of family planning in Finland from the 1960s to the 1990s.
  383. The difference between emergency contraception (ECPS) and early abortion options (RU 486)
  384. Differences in counseling men and women: family planning in Kenya.
  385. Disulphide peptides: new targets for contraceptive development.
  386. Do public attitudes toward abortion influence attitudes toward family planning? Findings from a survey of Americans.
  387. Doctors prefer oral contraceptives. Capsule.
  388. Does anovulation induced by oral contraceptives favor pregnancy during the following two menstrual cycles?
  389. Does birth control education increase knowledge among parenting / pregnant teenagers in residential treatment?
  390. Donor support for contraceptives and logistics, 1999.
  391. Drug interactions and combination oral contraceptives.
  392. Dual needs: contraceptive and infection protection in Lusaka, Zambia.
  393. The dynamics of fertility, family planning and female education in a developing economy.
  394. The editor's workshop. OTC access to emergency contraception: "The French model" -- What's your vote?
  395. Editorials: FY2001 international family planning funding and the global gag rule.
  396. Effectiveness of media messages in promoting family planning programme in Pakistan.
  397. Effects of child gender preference on contraceptive use in rural Bangladesh.
  398. Effects of three different methods of hormonal contraceptives on some coagulation and fibrinolytic parameters.
  399. Emergency contraception and the ethics of discussing it prior to the emergency.
  400. Emergency contraception for rape victims inadequate in New York. Half of the state's EDs don't offer it.
  401. Emergency contraception knowledge and prescribing practices: a comparison of primary care residents at a teaching hospital.
  402. Emergency contraception update.

     

  403. Emergency contraception update.
  404. Emergency contraception with levonorgestrel: one hormone better than two [editorial]
  405. Emergency contraception.
  406. Emergency contraception.
  407. Emergency contraception. It could reduce the number of unintended pregnancies by 50%.
  408. Emergency contraception: methods and efficacy.
  409. Emergency contraception: survey of knowledge, attitudes and practice of health care professionals in Ibadan, Nigeria.
  410. Emergency contraceptives over the counter. Allowing easy access is important.
  411. Emergency hormonal contraception.
  412. Epidemiological models and related simulation results for understanding of contraceptive adoption in India.
  413. Estimating the balance of general practice versus family planning clinic coverage of contraception services in London.
  414. Evaluating contraceptive use in Calabar.
  415. An evaluation of family planning and HIV counseling and testing campaigns, November 1998 - July 1999. Based on interviews with clients at 57 selected health facilities.
  416. Evaluation of Village Based Family Planning Workers Scheme in Pakistan.
  417. Evaluation on the effectiveness and feasibility of integrating STI / HIV counseling with existing family planning service in Shanghai.
  418. Expanding access to reproductive health through midwives. Family Planning Service Expansion and Technical Support. Lessons learned from SEATS' MAPS initiative.
  419. Experiences of and attitudes to contraceptive services among a sample of attenders at general practices in Dublin.
  420. Expression and cellular localization of contraception-associated protein 1.
  421. Extension of use of the contraceptive implants, Norplant and levonorgestrel rods to seven years.
  422. Factors affecting HIV contraceptive decision-making among women.
  423. Factors affecting use and non-use of contraceptives in Uttar Pradesh and Tamil Nadu: a comparative study based on NFHS-I data.
  424. Factors predictive of adolescents' intentions to use birth control pills, condoms, and birth control pills in combination with condoms. [Facteurs prédictifs de l'intention des adolescents d'utiliser la pilule, le préservatif et la combinaison des deux.]
  425. Family planning and demographic yearbook 1999. Volume 25.
  426. Family planning and fertility in Bangladesh.
  427. Family Planning and Maternal and Child Health Project in Morocco. Phase V. Consultation report, February 26 - March 7, 2000. Peer assessment of private sector general practitioners in family planning in Morocco. [Projet de Planification Familiale et Sante Maternelle et Infantile. Phase V. Rapport de consultation du 26 fevrier au 7 mars 2000. Evaluation par les pairs des medecins generalistes de pratique privee en planification familiale au Maroc.]
  428. Family Planning and Maternal and Child Health Project in Morocco. Phase V. Consultation report, May 6-14, 2000. Peer assessment of private sector general practitioners in family planning in Morocco. [Project de Planification Familiale et Sante Maternelle et Infantile. Phase V. Rapport de consultation du 6 au 14 mai 2000. Evaluation par les pairs des medecins generalistes du secteur prive en planification familiale au Maroc.]
  429. Family Planning and Maternal and Child Health Project in Morocco. Phase V. Consultation report. Support to the workshop on training in facilitation techniques for provincial staff in Morocco, January 24-31, 2000. [Projet de Planification Familiale et Sante Maternelle et Infantile. Phase V. Rapport de consultation. Appui a l'atelier de formation des animateurs de provinces en techniques de facilitation, au Maroc, 24 au 31 janvier, 2000.]
  430. Family Planning and Maternal and Child Health Project in Morocco. Phase V. Annual performance report, 2000. [Projet de Planification Familiale et Sante Maternelle et Infantile au Maroc. Phase V. Rapport annuel de performance 2000.]
  431. Family Planning and Maternal and Child Health Project. Phase V. Consultation report. Pilot phase: April 1998 - July 2000. Community component of the integrated management of childhood illness strategy. [Projet de Planification Familiale et Sante Maternelle et Infantile. Phase V. Rapport de consultation. Phase pilote: avril 1998 - juillet 2000. La composante communautaire de la strategie de la prise en charge integree des maladies de l'enfant.]
  432. Family planning and reproductive health in China.
  433. Family planning and reproductive health in China.
  434. Family planning counselling kit. Family planning counselling information for service providers, Republic of Zambia.
  435. Family planning financial analysis and projections for 1995 to 2020. Kenya.
  436. Family planning in China: for or against the woman? Evaluation of three decades. [La planification familiale en Chine, pour ou contre la femme? Bilan de trois decennies.]
  437. Family planning KAP survey in Gaza.
  438. Family Planning Management Development. Building sustainability through better management.
  439. Family planning policy in Tunisia, 1964-2000. [La politique de planification familiale en Tunisie (1964-2000)]
  440. Family planning programs, socioeconomic characteristics, and contraceptive use in Malawi.
  441. Family planning services and programmes in countries of the Eastern Mediterranean Region.
  442. Family planning services and public sector health care in Kerala.
  443. Family planning targeted to men. [Une planification familiale ciblee sur les hommes.]
  444. Family planning transition: retrospects and prospects (a state level study in Haryana)
  445. Family planning. [Planification familiale.]
  446. Family planning: making families stronger. A briefing sheet from Planned Parenthood Federation of America.
  447. Family planning: mantra for the millennium?
  448. First sexual intercourse and contraception: a cross-sectional survey on the sexuality of 16-20-year-olds in Switzerland.
  449. Fok nou fe planin: a family planning scene out of Port-au-Prince, Haiti] ["Fok nou fe planin": Familienplanungsszene von Port-au-Prince, Haiti.]
  450. Foreign assistance. USAID compliance with family planning restrictions. Report to the Chairman, Committee on Foreign Relations, U.S. Senate.
  451. From consent to choice in family planning: application of an international framework to the United States.
  452. Fulfilling the promise: public policy and U.S. family planning clinics.
  453. Future uncertain for Catholic plans' creative approaches to providing contraceptive access.
  454. Gains in contraceptive use may spur abortion drops.
  455. Ghana: implications of health sector reform for contraceptive logistics.
  456. The global challenges for family planning in the 21st century.
  457. Global gag rule threatens international family planning programs.
  458. Guidance April 2000. Emergency contraception: recommendations for clinical practice.
  459. Has Canadian contraceptive use really declined? [letter]
  460. Has Canadian contraceptive use really declined? The authors reply [letter]
  461. Health and Family Planning Accessibility Survey, 1996-97.
  462. Health issues in the Parliament. Ban on injectible contraceptives.
  463. Help patients obtain emergency contraception.
  464. Historical review of the combined oral contraceptive pill and injectable progestogens.
  465. Hormonal contraception and weight issues.
  466. Hormone withdrawal symptoms in oral contraceptive users. [ Symptômes de l'état de manque d'hormones chez les utilisateurs de contraceptives oraux]]
  467. How does family planning influence women's lives?
  468. How effective are family planning clinics? [letter]
  469. How youth friendly are family planning services? A simulated client study in Tanga municipality.
  470. Imagined men: representations of masculinities in discourses on male contraceptive technology.
  471. The impact of family planning on women's lives: the research process in the Philippines.
  472. Impact of son preference on contraceptive use in Uttar Pradesh.
  473. The impact of targeted family planning programs in Indonesia.
  474. The impact of the quality of family planning services on safe and effective contraceptive use: a systematic literature review.
  475. Implications of health sector reform for contraceptive logistics: a preliminary assessment for sub-Saharan Africa.
  476. Implications of health sector reform for contraceptive logistics: a preliminary assessment for sub-Saharan Africa.
  477. Improving access to emergency contraception.
  478. Improving access to emergency contraception: UK, France and Brazil.
  479. Improving access to quality care in family planning. Medical eligibility criteria for contraceptive use. 2nd ed.
  480. In-depth interviews with married men and women who are current family planning users. "We trust each other".
  481. Include family planning in managed care contracts.
  482. Increased use of contraception in Kazakhstan contributes to abortion decline.
  483. Influence of male education on family planning decisions.
  484. Influence of son preference on contraceptive use in Bangladesh.
  485. Influences of hormonal contraceptives on sexual satisfaction. [Influencia de los anticonceptivos hormonales sobre la satisfacción sexual.]
  486. Injectable intravasal contraceptive for the male.
  487. The institutionalization and "medicalization" of family planning in Tonga.
  488. Integrating issues of sexuality into Egyptian family planning counseling.
  489. Integration of family planning and HIV / AIDS / STD.
  490. Interactions with hormonal contraception. Faculty Aid to CPD Topics (FACT). A CPD self-assessment test. Review No. 2000/02.
  491. International family planning: saving women's lives, protecting women's health.
  492. The intrauterine device: family planning method standards in Morocco. [Le dispositif intra-uterin: les standars des methodes de planification familiale au Maroc.]
  493. Is education the best contraceptive?
  494. Knowledge among German and Turkish women about specifically female bodily functions, contraception, preventative medical examinations and menopause.
  495. Levels and trends of contraceptive use as assessed in 1998.
  496. The levonorgestrel intrauterine system in contraception.
  497. Levonorgestrel system offers several benefits. Contraceptive update.
  498. Long-term and permanent family planning methods in Uganda: a literature review.
  499. Lusaka impact study: "Changes in contraceptive use dynamics after the introduction of Norplant." Results of the baseline data and first follow-up.
  500. Mainstreaming quality improvement in family planning and reproductive health services delivery. Context and case studies.

To view other lists of the current category of articles, please visit "Category Lists Homepage"


Web PubHealth.info

© Copyrights PubHealth.info®, an information portal on public health. All rights reserved.

This page is optimized to be viewed by Java script enabled Microsoft® Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels.